nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.38	0.5	CpDpCtD
Entacapone—Parkinson's disease—Memantine—Alzheimer's disease	0.38	0.5	CpDpCtD
Entacapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—Alzheimer's disease	0.00303	0.0924	CbGpPWpGaD
Entacapone—COMT—telencephalic ventricle—Alzheimer's disease	0.0029	0.495	CbGeAlD
Entacapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—Alzheimer's disease	0.00264	0.0805	CbGpPWpGaD
Entacapone—COMT—Dopamine metabolism—MAOB—Alzheimer's disease	0.00254	0.0775	CbGpPWpGaD
Entacapone—COMT—Biogenic Amine Synthesis—CHAT—Alzheimer's disease	0.00236	0.072	CbGpPWpGaD
Entacapone—COMT—Biogenic Amine Synthesis—ACHE—Alzheimer's disease	0.00183	0.0559	CbGpPWpGaD
Entacapone—COMT—Dopamine metabolism—SOD1—Alzheimer's disease	0.00146	0.0445	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.0012	0.0365	CbGpPWpGaD
Entacapone—UGT1A9—Irinotecan Pathway—BCHE—Alzheimer's disease	0.00101	0.0308	CbGpPWpGaD
Entacapone—COMT—forebrain—Alzheimer's disease	0.000757	0.129	CbGeAlD
Entacapone—COMT—telencephalon—Alzheimer's disease	0.000696	0.119	CbGeAlD
Entacapone—COMT—Biological oxidations—CYP46A1—Alzheimer's disease	0.000539	0.0164	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000532	0.0162	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000496	0.0151	CbGpPWpGaD
Entacapone—COMT—nervous system—Alzheimer's disease	0.000411	0.0701	CbGeAlD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000411	0.0125	CbGpPWpGaD
Entacapone—COMT—central nervous system—Alzheimer's disease	0.000396	0.0675	CbGeAlD
Entacapone—COMT—cerebellum—Alzheimer's disease	0.000387	0.066	CbGeAlD
Entacapone—COMT—Neuronal System—SLC18A3—Alzheimer's disease	0.00038	0.0116	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.00035	0.0107	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.00035	0.0107	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP46A1—Alzheimer's disease	0.000323	0.00985	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—MAOB—Alzheimer's disease	0.000322	0.00981	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000318	0.00972	CbGpPWpGaD
Entacapone—COMT—brain—Alzheimer's disease	0.000314	0.0536	CbGeAlD
Entacapone—COMT—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000297	0.00907	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000297	0.00907	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	0.000278	0.00848	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNA7—Alzheimer's disease	0.000268	0.00817	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIK1—Alzheimer's disease	0.000268	0.00817	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000265	0.00809	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000251	0.00766	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—PTGS1—Alzheimer's disease	0.000244	0.00744	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP2D6—Alzheimer's disease	0.000239	0.00729	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000236	0.00719	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000231	0.00703	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000228	0.00695	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIK2—Alzheimer's disease	0.000228	0.00695	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHAT—Alzheimer's disease	0.000228	0.00695	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIA1—Alzheimer's disease	0.000203	0.00619	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000201	0.00613	CbGpPWpGaD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000196	0.000971	CcSEcCtD
Entacapone—Sinusitis—Memantine—Alzheimer's disease	0.000196	0.00097	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000196	0.00598	CbGpPWpGaD
Entacapone—Sweating—Rivastigmine—Alzheimer's disease	0.000196	0.00097	CcSEcCtD
Entacapone—Discomfort—Galantamine—Alzheimer's disease	0.000195	0.000966	CcSEcCtD
Entacapone—Agranulocytosis—Memantine—Alzheimer's disease	0.000195	0.000965	CcSEcCtD
Entacapone—Haematuria—Rivastigmine—Alzheimer's disease	0.000195	0.000965	CcSEcCtD
Entacapone—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000193	0.000957	CcSEcCtD
Entacapone—Dry mouth—Galantamine—Alzheimer's disease	0.000193	0.000956	CcSEcCtD
Entacapone—Epistaxis—Rivastigmine—Alzheimer's disease	0.000193	0.000954	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—MAOB—Alzheimer's disease	0.000193	0.00588	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNB2—Alzheimer's disease	0.000192	0.00587	CbGpPWpGaD
Entacapone—Sinusitis—Rivastigmine—Alzheimer's disease	0.000192	0.000949	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000192	0.00585	CbGpPWpGaD
Entacapone—Confusional state—Galantamine—Alzheimer's disease	0.000191	0.000945	CcSEcCtD
Entacapone—Bradycardia—Memantine—Alzheimer's disease	0.000191	0.000945	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000189	0.00578	CbGpPWpGaD
Entacapone—Haemoglobin—Memantine—Alzheimer's disease	0.000189	0.000933	CcSEcCtD
Entacapone—Haemorrhage—Memantine—Alzheimer's disease	0.000188	0.000928	CcSEcCtD
Entacapone—Hepatitis—Memantine—Alzheimer's disease	0.000188	0.000928	CcSEcCtD
Entacapone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000187	0.000925	CcSEcCtD
Entacapone—Hallucination—Memantine—Alzheimer's disease	0.000187	0.000924	CcSEcCtD
Entacapone—Hypoaesthesia—Memantine—Alzheimer's disease	0.000187	0.000924	CcSEcCtD
Entacapone—Shock—Galantamine—Alzheimer's disease	0.000186	0.000922	CcSEcCtD
Entacapone—Pharyngitis—Memantine—Alzheimer's disease	0.000186	0.000921	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000186	0.00567	CbGpPWpGaD
Entacapone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000186	0.000919	CcSEcCtD
Entacapone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000185	0.000918	CcSEcCtD
Entacapone—Urinary tract disorder—Memantine—Alzheimer's disease	0.000185	0.000917	CcSEcCtD
Entacapone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000184	0.000913	CcSEcCtD
Entacapone—Skin disorder—Galantamine—Alzheimer's disease	0.000184	0.000911	CcSEcCtD
Entacapone—Urethral disorder—Memantine—Alzheimer's disease	0.000184	0.00091	CcSEcCtD
Entacapone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000183	0.000908	CcSEcCtD
Entacapone—Hepatitis—Rivastigmine—Alzheimer's disease	0.000183	0.000908	CcSEcCtD
Entacapone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000183	0.000906	CcSEcCtD
Entacapone—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000183	0.000904	CcSEcCtD
Entacapone—Hallucination—Rivastigmine—Alzheimer's disease	0.000183	0.000904	CcSEcCtD
Entacapone—Alopecia—Donepezil—Alzheimer's disease	0.000183	0.000904	CcSEcCtD
Entacapone—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000182	0.000901	CcSEcCtD
Entacapone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000181	0.000897	CcSEcCtD
Entacapone—Mental disorder—Donepezil—Alzheimer's disease	0.000181	0.000896	CcSEcCtD
Entacapone—Visual impairment—Memantine—Alzheimer's disease	0.000181	0.000895	CcSEcCtD
Entacapone—Anorexia—Galantamine—Alzheimer's disease	0.000181	0.000894	CcSEcCtD
Entacapone—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00018	0.00089	CcSEcCtD
Entacapone—Malnutrition—Donepezil—Alzheimer's disease	0.00018	0.00089	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—ABCA1—Alzheimer's disease	0.000178	0.00542	CbGpPWpGaD
Entacapone—Erythema multiforme—Memantine—Alzheimer's disease	0.000177	0.000878	CcSEcCtD
Entacapone—Flatulence—Donepezil—Alzheimer's disease	0.000177	0.000877	CcSEcCtD
Entacapone—Hypotension—Galantamine—Alzheimer's disease	0.000177	0.000876	CcSEcCtD
Entacapone—Visual impairment—Rivastigmine—Alzheimer's disease	0.000177	0.000875	CcSEcCtD
Entacapone—COMT—Neuronal System—ACHE—Alzheimer's disease	0.000177	0.00539	CbGpPWpGaD
Entacapone—Tension—Donepezil—Alzheimer's disease	0.000176	0.000874	CcSEcCtD
Entacapone—Dysgeusia—Donepezil—Alzheimer's disease	0.000176	0.000872	CcSEcCtD
Entacapone—Eye disorder—Memantine—Alzheimer's disease	0.000175	0.000868	CcSEcCtD
Entacapone—Nervousness—Donepezil—Alzheimer's disease	0.000175	0.000865	CcSEcCtD
Entacapone—COMT—Neuronal System—CHRNA4—Alzheimer's disease	0.000175	0.00533	CbGpPWpGaD
Entacapone—Cardiac disorder—Memantine—Alzheimer's disease	0.000174	0.000862	CcSEcCtD
Entacapone—Flushing—Memantine—Alzheimer's disease	0.000174	0.000862	CcSEcCtD
Entacapone—Back pain—Donepezil—Alzheimer's disease	0.000174	0.000861	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—Alzheimer's disease	0.000174	0.0053	CbGpPWpGaD
Entacapone—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000173	0.000859	CcSEcCtD
Entacapone—Muscle spasms—Donepezil—Alzheimer's disease	0.000173	0.000856	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000173	0.000854	CcSEcCtD
Entacapone—Eye disorder—Rivastigmine—Alzheimer's disease	0.000171	0.000849	CcSEcCtD
Entacapone—Insomnia—Galantamine—Alzheimer's disease	0.000171	0.000848	CcSEcCtD
Entacapone—Flushing—Rivastigmine—Alzheimer's disease	0.00017	0.000843	CcSEcCtD
Entacapone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00017	0.000843	CcSEcCtD
Entacapone—Paraesthesia—Galantamine—Alzheimer's disease	0.00017	0.000842	CcSEcCtD
Entacapone—Vision blurred—Donepezil—Alzheimer's disease	0.000169	0.000839	CcSEcCtD
Entacapone—Tremor—Donepezil—Alzheimer's disease	0.000168	0.000834	CcSEcCtD
Entacapone—Somnolence—Galantamine—Alzheimer's disease	0.000168	0.000833	CcSEcCtD
Entacapone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000167	0.000826	CcSEcCtD
Entacapone—Dyspepsia—Galantamine—Alzheimer's disease	0.000167	0.000825	CcSEcCtD
Entacapone—Alopecia—Memantine—Alzheimer's disease	0.000166	0.00082	CcSEcCtD
Entacapone—Agitation—Donepezil—Alzheimer's disease	0.000165	0.000818	CcSEcCtD
Entacapone—Decreased appetite—Galantamine—Alzheimer's disease	0.000165	0.000815	CcSEcCtD
Entacapone—Mental disorder—Memantine—Alzheimer's disease	0.000164	0.000813	CcSEcCtD
Entacapone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000163	0.000809	CcSEcCtD
Entacapone—Malnutrition—Memantine—Alzheimer's disease	0.000163	0.000808	CcSEcCtD
Entacapone—Fatigue—Galantamine—Alzheimer's disease	0.000163	0.000808	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000163	0.00498	CbGpPWpGaD
Entacapone—Malaise—Donepezil—Alzheimer's disease	0.000162	0.000803	CcSEcCtD
Entacapone—Alopecia—Rivastigmine—Alzheimer's disease	0.000162	0.000803	CcSEcCtD
Entacapone—Constipation—Galantamine—Alzheimer's disease	0.000162	0.000802	CcSEcCtD
Entacapone—Vertigo—Donepezil—Alzheimer's disease	0.000162	0.0008	CcSEcCtD
Entacapone—Syncope—Donepezil—Alzheimer's disease	0.000161	0.000798	CcSEcCtD
Entacapone—Flatulence—Memantine—Alzheimer's disease	0.000161	0.000796	CcSEcCtD
Entacapone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000161	0.000796	CcSEcCtD
Entacapone—Tension—Memantine—Alzheimer's disease	0.00016	0.000793	CcSEcCtD
Entacapone—Dysgeusia—Memantine—Alzheimer's disease	0.00016	0.000791	CcSEcCtD
Entacapone—Malnutrition—Rivastigmine—Alzheimer's disease	0.00016	0.000791	CcSEcCtD
Entacapone—Nervousness—Memantine—Alzheimer's disease	0.000159	0.000785	CcSEcCtD
Entacapone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000158	0.000782	CcSEcCtD
Entacapone—Back pain—Memantine—Alzheimer's disease	0.000158	0.000782	CcSEcCtD
Entacapone—Flatulence—Rivastigmine—Alzheimer's disease	0.000157	0.000779	CcSEcCtD
Entacapone—Cough—Donepezil—Alzheimer's disease	0.000157	0.000777	CcSEcCtD
Entacapone—Tension—Rivastigmine—Alzheimer's disease	0.000157	0.000776	CcSEcCtD
Entacapone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000156	0.000774	CcSEcCtD
Entacapone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000156	0.000772	CcSEcCtD
Entacapone—Convulsion—Donepezil—Alzheimer's disease	0.000156	0.000771	CcSEcCtD
Entacapone—Hypertension—Donepezil—Alzheimer's disease	0.000155	0.000769	CcSEcCtD
Entacapone—Nervousness—Rivastigmine—Alzheimer's disease	0.000155	0.000768	CcSEcCtD
Entacapone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000155	0.000767	CcSEcCtD
Entacapone—Back pain—Rivastigmine—Alzheimer's disease	0.000155	0.000765	CcSEcCtD
Entacapone—Vision blurred—Memantine—Alzheimer's disease	0.000154	0.000762	CcSEcCtD
Entacapone—COMT—Neuronal System—BCHE—Alzheimer's disease	0.000154	0.00469	CbGpPWpGaD
Entacapone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000154	0.00076	CcSEcCtD
Entacapone—Myalgia—Donepezil—Alzheimer's disease	0.000153	0.000758	CcSEcCtD
Entacapone—Chest pain—Donepezil—Alzheimer's disease	0.000153	0.000758	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—PPARGC1A—Alzheimer's disease	0.000153	0.00467	CbGpPWpGaD
Entacapone—Tremor—Memantine—Alzheimer's disease	0.000153	0.000757	CcSEcCtD
Entacapone—Anxiety—Donepezil—Alzheimer's disease	0.000153	0.000755	CcSEcCtD
Entacapone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000151	0.00075	CcSEcCtD
Entacapone—Discomfort—Donepezil—Alzheimer's disease	0.000151	0.000749	CcSEcCtD
Entacapone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000151	0.000745	CcSEcCtD
Entacapone—COMT—Neuronal System—DLG4—Alzheimer's disease	0.00015	0.00458	CbGpPWpGaD
Entacapone—Agitation—Memantine—Alzheimer's disease	0.00015	0.000743	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARGC1A—Alzheimer's disease	0.00015	0.00457	CbGpPWpGaD
Entacapone—Dry mouth—Donepezil—Alzheimer's disease	0.00015	0.000741	CcSEcCtD
Entacapone—Body temperature increased—Galantamine—Alzheimer's disease	0.00015	0.000741	CcSEcCtD
Entacapone—Abdominal pain—Galantamine—Alzheimer's disease	0.00015	0.000741	CcSEcCtD
Entacapone—Tremor—Rivastigmine—Alzheimer's disease	0.00015	0.000741	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	0.00015	0.00456	CbGpPWpGaD
Entacapone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000148	0.000734	CcSEcCtD
Entacapone—Confusional state—Donepezil—Alzheimer's disease	0.000148	0.000733	CcSEcCtD
Entacapone—Malaise—Memantine—Alzheimer's disease	0.000147	0.000729	CcSEcCtD
Entacapone—Agitation—Rivastigmine—Alzheimer's disease	0.000147	0.000727	CcSEcCtD
Entacapone—COMT—Neuronal System—GRIN2B—Alzheimer's disease	0.000147	0.00448	CbGpPWpGaD
Entacapone—Oedema—Donepezil—Alzheimer's disease	0.000147	0.000726	CcSEcCtD
Entacapone—Vertigo—Memantine—Alzheimer's disease	0.000147	0.000726	CcSEcCtD
Entacapone—Syncope—Memantine—Alzheimer's disease	0.000146	0.000725	CcSEcCtD
Entacapone—Leukopenia—Memantine—Alzheimer's disease	0.000146	0.000723	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—PTGS1—Alzheimer's disease	0.000146	0.00445	CbGpPWpGaD
Entacapone—COMT—Neuronal System—PLCB1—Alzheimer's disease	0.000145	0.00443	CbGpPWpGaD
Entacapone—Shock—Donepezil—Alzheimer's disease	0.000144	0.000715	CcSEcCtD
Entacapone—Palpitations—Memantine—Alzheimer's disease	0.000144	0.000714	CcSEcCtD
Entacapone—Malaise—Rivastigmine—Alzheimer's disease	0.000144	0.000713	CcSEcCtD
Entacapone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000144	0.000712	CcSEcCtD
Entacapone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000144	0.000711	CcSEcCtD
Entacapone—Vertigo—Rivastigmine—Alzheimer's disease	0.000144	0.00071	CcSEcCtD
Entacapone—Loss of consciousness—Memantine—Alzheimer's disease	0.000144	0.00071	CcSEcCtD
Entacapone—Syncope—Rivastigmine—Alzheimer's disease	0.000143	0.000709	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—CYP2D6—Alzheimer's disease	0.000143	0.00437	CbGpPWpGaD
Entacapone—Cough—Memantine—Alzheimer's disease	0.000142	0.000705	CcSEcCtD
Entacapone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000142	0.000702	CcSEcCtD
Entacapone—Convulsion—Memantine—Alzheimer's disease	0.000141	0.0007	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000141	0.00431	CbGpPWpGaD
Entacapone—Palpitations—Rivastigmine—Alzheimer's disease	0.000141	0.000699	CcSEcCtD
Entacapone—Hypertension—Memantine—Alzheimer's disease	0.000141	0.000698	CcSEcCtD
Entacapone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00014	0.000695	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.00014	0.00428	CbGpPWpGaD
Entacapone—Anorexia—Donepezil—Alzheimer's disease	0.00014	0.000692	CcSEcCtD
Entacapone—Hypersensitivity—Galantamine—Alzheimer's disease	0.00014	0.000691	CcSEcCtD
Entacapone—Cough—Rivastigmine—Alzheimer's disease	0.000139	0.00069	CcSEcCtD
Entacapone—Chest pain—Memantine—Alzheimer's disease	0.000139	0.000688	CcSEcCtD
Entacapone—Myalgia—Memantine—Alzheimer's disease	0.000139	0.000688	CcSEcCtD
Entacapone—Anxiety—Memantine—Alzheimer's disease	0.000139	0.000686	CcSEcCtD
Entacapone—Convulsion—Rivastigmine—Alzheimer's disease	0.000138	0.000685	CcSEcCtD
Entacapone—COMT—Metabolism—DHCR24—Alzheimer's disease	0.000138	0.00421	CbGpPWpGaD
Entacapone—Hypertension—Rivastigmine—Alzheimer's disease	0.000138	0.000683	CcSEcCtD
Entacapone—Discomfort—Memantine—Alzheimer's disease	0.000137	0.00068	CcSEcCtD
Entacapone—Hypotension—Donepezil—Alzheimer's disease	0.000137	0.000679	CcSEcCtD
Entacapone—Chest pain—Rivastigmine—Alzheimer's disease	0.000136	0.000673	CcSEcCtD
Entacapone—Myalgia—Rivastigmine—Alzheimer's disease	0.000136	0.000673	CcSEcCtD
Entacapone—Dry mouth—Memantine—Alzheimer's disease	0.000136	0.000673	CcSEcCtD
Entacapone—Asthenia—Galantamine—Alzheimer's disease	0.000136	0.000673	CcSEcCtD
Entacapone—Anxiety—Rivastigmine—Alzheimer's disease	0.000136	0.000671	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000135	0.000669	CcSEcCtD
Entacapone—Confusional state—Memantine—Alzheimer's disease	0.000134	0.000665	CcSEcCtD
Entacapone—Discomfort—Rivastigmine—Alzheimer's disease	0.000134	0.000665	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000134	0.0041	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000134	0.000662	CcSEcCtD
Entacapone—Oedema—Memantine—Alzheimer's disease	0.000133	0.00066	CcSEcCtD
Entacapone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000133	0.000658	CcSEcCtD
Entacapone—Insomnia—Donepezil—Alzheimer's disease	0.000133	0.000657	CcSEcCtD
Entacapone—Paraesthesia—Donepezil—Alzheimer's disease	0.000132	0.000652	CcSEcCtD
Entacapone—Confusional state—Rivastigmine—Alzheimer's disease	0.000131	0.000651	CcSEcCtD
Entacapone—Shock—Memantine—Alzheimer's disease	0.000131	0.000649	CcSEcCtD
Entacapone—Dyspnoea—Donepezil—Alzheimer's disease	0.000131	0.000648	CcSEcCtD
Entacapone—Nervous system disorder—Memantine—Alzheimer's disease	0.000131	0.000647	CcSEcCtD
Entacapone—Somnolence—Donepezil—Alzheimer's disease	0.00013	0.000646	CcSEcCtD
Entacapone—Thrombocytopenia—Memantine—Alzheimer's disease	0.00013	0.000646	CcSEcCtD
Entacapone—Oedema—Rivastigmine—Alzheimer's disease	0.00013	0.000645	CcSEcCtD
Entacapone—Diarrhoea—Galantamine—Alzheimer's disease	0.00013	0.000641	CcSEcCtD
Entacapone—Skin disorder—Memantine—Alzheimer's disease	0.000129	0.000641	CcSEcCtD
Entacapone—Dyspepsia—Donepezil—Alzheimer's disease	0.000129	0.000639	CcSEcCtD
Entacapone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000129	0.000638	CcSEcCtD
Entacapone—Shock—Rivastigmine—Alzheimer's disease	0.000128	0.000635	CcSEcCtD
Entacapone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000128	0.000633	CcSEcCtD
Entacapone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000128	0.000632	CcSEcCtD
Entacapone—Decreased appetite—Donepezil—Alzheimer's disease	0.000128	0.000632	CcSEcCtD
Entacapone—Anorexia—Memantine—Alzheimer's disease	0.000127	0.000629	CcSEcCtD
Entacapone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000127	0.000627	CcSEcCtD
Entacapone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000127	0.000627	CcSEcCtD
Entacapone—Fatigue—Donepezil—Alzheimer's disease	0.000127	0.000626	CcSEcCtD
Entacapone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000126	0.000624	CcSEcCtD
Entacapone—Constipation—Donepezil—Alzheimer's disease	0.000126	0.000621	CcSEcCtD
Entacapone—Pain—Donepezil—Alzheimer's disease	0.000126	0.000621	CcSEcCtD
Entacapone—Dizziness—Galantamine—Alzheimer's disease	0.000125	0.00062	CcSEcCtD
Entacapone—Hypotension—Memantine—Alzheimer's disease	0.000125	0.000616	CcSEcCtD
Entacapone—Anorexia—Rivastigmine—Alzheimer's disease	0.000124	0.000615	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000124	0.00378	CbGpPWpGaD
Entacapone—Hypotension—Rivastigmine—Alzheimer's disease	0.000122	0.000603	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—HMOX1—Alzheimer's disease	0.000121	0.00371	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000121	0.000601	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000121	0.0037	CbGpPWpGaD
Entacapone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000121	0.000599	CcSEcCtD
Entacapone—Insomnia—Memantine—Alzheimer's disease	0.000121	0.000597	CcSEcCtD
Entacapone—Vomiting—Galantamine—Alzheimer's disease	0.00012	0.000596	CcSEcCtD
Entacapone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00012	0.000594	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—Alzheimer's disease	0.00012	0.00365	CbGpPWpGaD
Entacapone—Paraesthesia—Memantine—Alzheimer's disease	0.00012	0.000592	CcSEcCtD
Entacapone—Rash—Galantamine—Alzheimer's disease	0.000119	0.000591	CcSEcCtD
Entacapone—Dermatitis—Galantamine—Alzheimer's disease	0.000119	0.000591	CcSEcCtD
Entacapone—Dyspnoea—Memantine—Alzheimer's disease	0.000119	0.000588	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000119	0.000588	CcSEcCtD
Entacapone—Headache—Galantamine—Alzheimer's disease	0.000119	0.000587	CcSEcCtD
Entacapone—Somnolence—Memantine—Alzheimer's disease	0.000118	0.000586	CcSEcCtD
Entacapone—Insomnia—Rivastigmine—Alzheimer's disease	0.000118	0.000584	CcSEcCtD
Entacapone—COMT—Metabolism—CA4—Alzheimer's disease	0.000117	0.00358	CbGpPWpGaD
Entacapone—Dyspepsia—Memantine—Alzheimer's disease	0.000117	0.000581	CcSEcCtD
Entacapone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000117	0.000579	CcSEcCtD
Entacapone—Urticaria—Donepezil—Alzheimer's disease	0.000117	0.000577	CcSEcCtD
Entacapone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000116	0.000575	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	0.000116	0.00354	CbGpPWpGaD
Entacapone—Body temperature increased—Donepezil—Alzheimer's disease	0.000116	0.000574	CcSEcCtD
Entacapone—Abdominal pain—Donepezil—Alzheimer's disease	0.000116	0.000574	CcSEcCtD
Entacapone—Somnolence—Rivastigmine—Alzheimer's disease	0.000116	0.000574	CcSEcCtD
Entacapone—Decreased appetite—Memantine—Alzheimer's disease	0.000116	0.000573	CcSEcCtD
Entacapone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000115	0.000569	CcSEcCtD
Entacapone—Fatigue—Memantine—Alzheimer's disease	0.000115	0.000569	CcSEcCtD
Entacapone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000115	0.000568	CcSEcCtD
Entacapone—Pain—Memantine—Alzheimer's disease	0.000114	0.000564	CcSEcCtD
Entacapone—Constipation—Memantine—Alzheimer's disease	0.000114	0.000564	CcSEcCtD
Entacapone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000113	0.000561	CcSEcCtD
Entacapone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000113	0.000557	CcSEcCtD
Entacapone—Nausea—Galantamine—Alzheimer's disease	0.000112	0.000557	CcSEcCtD
Entacapone—Fatigue—Rivastigmine—Alzheimer's disease	0.000112	0.000556	CcSEcCtD
Entacapone—Pain—Rivastigmine—Alzheimer's disease	0.000111	0.000552	CcSEcCtD
Entacapone—Constipation—Rivastigmine—Alzheimer's disease	0.000111	0.000552	CcSEcCtD
Entacapone—COMT—Metabolism—GAPDHS—Alzheimer's disease	0.00011	0.00337	CbGpPWpGaD
Entacapone—Feeling abnormal—Memantine—Alzheimer's disease	0.00011	0.000544	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—AGER—Alzheimer's disease	0.000109	0.00333	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000109	0.000539	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	0.000108	0.00331	CbGpPWpGaD
Entacapone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000108	0.000535	CcSEcCtD
Entacapone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000107	0.000532	CcSEcCtD
Entacapone—COMT—Neuronal System—PRKCG—Alzheimer's disease	0.000107	0.00328	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000107	0.000528	CcSEcCtD
Entacapone—Urticaria—Memantine—Alzheimer's disease	0.000106	0.000524	CcSEcCtD
Entacapone—Abdominal pain—Memantine—Alzheimer's disease	0.000105	0.000521	CcSEcCtD
Entacapone—Body temperature increased—Memantine—Alzheimer's disease	0.000105	0.000521	CcSEcCtD
Entacapone—Asthenia—Donepezil—Alzheimer's disease	0.000105	0.000521	CcSEcCtD
Entacapone—COMT—Metabolism—ATP5A1—Alzheimer's disease	0.000105	0.00319	CbGpPWpGaD
Entacapone—Pruritus—Donepezil—Alzheimer's disease	0.000104	0.000514	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000104	0.00317	CbGpPWpGaD
Entacapone—Urticaria—Rivastigmine—Alzheimer's disease	0.000104	0.000513	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—Alzheimer's disease	0.000103	0.00315	CbGpPWpGaD
Entacapone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000103	0.00051	CcSEcCtD
Entacapone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000103	0.00051	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—PPARG—Alzheimer's disease	0.000102	0.0031	CbGpPWpGaD
Entacapone—Diarrhoea—Donepezil—Alzheimer's disease	0.0001	0.000497	CcSEcCtD
Entacapone—COMT—Metabolism—PLD3—Alzheimer's disease	9.99e-05	0.00305	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Alzheimer's disease	9.95e-05	0.00304	CbGpPWpGaD
Entacapone—Hypersensitivity—Memantine—Alzheimer's disease	9.82e-05	0.000486	CcSEcCtD
Entacapone—Dizziness—Donepezil—Alzheimer's disease	9.71e-05	0.00048	CcSEcCtD
Entacapone—Hypersensitivity—Rivastigmine—Alzheimer's disease	9.6e-05	0.000475	CcSEcCtD
Entacapone—COMT—Metabolism—HSD17B10—Alzheimer's disease	9.58e-05	0.00292	CbGpPWpGaD
Entacapone—Asthenia—Memantine—Alzheimer's disease	9.56e-05	0.000473	CcSEcCtD
Entacapone—Pruritus—Memantine—Alzheimer's disease	9.43e-05	0.000467	CcSEcCtD
Entacapone—Asthenia—Rivastigmine—Alzheimer's disease	9.35e-05	0.000463	CcSEcCtD
Entacapone—Vomiting—Donepezil—Alzheimer's disease	9.33e-05	0.000462	CcSEcCtD
Entacapone—COMT—Neuronal System—CALM1—Alzheimer's disease	9.29e-05	0.00283	CbGpPWpGaD
Entacapone—Rash—Donepezil—Alzheimer's disease	9.25e-05	0.000458	CcSEcCtD
Entacapone—Dermatitis—Donepezil—Alzheimer's disease	9.25e-05	0.000458	CcSEcCtD
Entacapone—Pruritus—Rivastigmine—Alzheimer's disease	9.22e-05	0.000457	CcSEcCtD
Entacapone—COMT—Metabolism—CYP46A1—Alzheimer's disease	9.22e-05	0.00281	CbGpPWpGaD
Entacapone—Headache—Donepezil—Alzheimer's disease	9.19e-05	0.000455	CcSEcCtD
Entacapone—Diarrhoea—Memantine—Alzheimer's disease	9.12e-05	0.000451	CcSEcCtD
Entacapone—Diarrhoea—Rivastigmine—Alzheimer's disease	8.92e-05	0.000442	CcSEcCtD
Entacapone—COMT—Metabolism—ND1—Alzheimer's disease	8.9e-05	0.00272	CbGpPWpGaD
Entacapone—Dizziness—Memantine—Alzheimer's disease	8.81e-05	0.000436	CcSEcCtD
Entacapone—Nausea—Donepezil—Alzheimer's disease	8.72e-05	0.000432	CcSEcCtD
Entacapone—Dizziness—Rivastigmine—Alzheimer's disease	8.62e-05	0.000427	CcSEcCtD
Entacapone—Vomiting—Memantine—Alzheimer's disease	8.47e-05	0.000419	CcSEcCtD
Entacapone—Rash—Memantine—Alzheimer's disease	8.4e-05	0.000416	CcSEcCtD
Entacapone—Dermatitis—Memantine—Alzheimer's disease	8.39e-05	0.000416	CcSEcCtD
Entacapone—Headache—Memantine—Alzheimer's disease	8.35e-05	0.000413	CcSEcCtD
Entacapone—Vomiting—Rivastigmine—Alzheimer's disease	8.29e-05	0.00041	CcSEcCtD
Entacapone—UGT1A9—Metabolism—DHCR24—Alzheimer's disease	8.28e-05	0.00253	CbGpPWpGaD
Entacapone—Rash—Rivastigmine—Alzheimer's disease	8.22e-05	0.000407	CcSEcCtD
Entacapone—Dermatitis—Rivastigmine—Alzheimer's disease	8.21e-05	0.000406	CcSEcCtD
Entacapone—Headache—Rivastigmine—Alzheimer's disease	8.17e-05	0.000404	CcSEcCtD
Entacapone—COMT—Neuronal System—CREB1—Alzheimer's disease	7.95e-05	0.00243	CbGpPWpGaD
Entacapone—Nausea—Memantine—Alzheimer's disease	7.92e-05	0.000392	CcSEcCtD
Entacapone—Nausea—Rivastigmine—Alzheimer's disease	7.74e-05	0.000383	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	7.72e-05	0.00235	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CA4—Alzheimer's disease	7.04e-05	0.00215	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	6.88e-05	0.0021	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Alzheimer's disease	6.86e-05	0.00209	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GAPDHS—Alzheimer's disease	6.62e-05	0.00202	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ATP5A1—Alzheimer's disease	6.27e-05	0.00191	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLD3—Alzheimer's disease	5.98e-05	0.00183	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.98e-05	0.00183	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.91e-05	0.0018	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD17B10—Alzheimer's disease	5.74e-05	0.00175	CbGpPWpGaD
Entacapone—COMT—Metabolism—TPI1—Alzheimer's disease	5.74e-05	0.00175	CbGpPWpGaD
Entacapone—COMT—Metabolism—CHAT—Alzheimer's disease	5.74e-05	0.00175	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.61e-05	0.00171	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP46A1—Alzheimer's disease	5.52e-05	0.00168	CbGpPWpGaD
Entacapone—COMT—Metabolism—MAOB—Alzheimer's disease	5.5e-05	0.00168	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ND1—Alzheimer's disease	5.33e-05	0.00163	CbGpPWpGaD
Entacapone—COMT—Metabolism—GAPDH—Alzheimer's disease	5.29e-05	0.00162	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.21e-05	0.00159	CbGpPWpGaD
Entacapone—COMT—Metabolism—A2M—Alzheimer's disease	5.11e-05	0.00156	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.77e-05	0.00145	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFB1—Alzheimer's disease	4.61e-05	0.00141	CbGpPWpGaD
Entacapone—COMT—Metabolism—ACHE—Alzheimer's disease	4.45e-05	0.00136	CbGpPWpGaD
Entacapone—COMT—Metabolism—INPP5D—Alzheimer's disease	4.4e-05	0.00134	CbGpPWpGaD
Entacapone—COMT—Metabolism—ENO1—Alzheimer's disease	4.17e-05	0.00127	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS1—Alzheimer's disease	4.17e-05	0.00127	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.11e-05	0.00125	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2D6—Alzheimer's disease	4.09e-05	0.00125	CbGpPWpGaD
Entacapone—COMT—Metabolism—BCHE—Alzheimer's disease	3.87e-05	0.00118	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.74e-05	0.00114	CbGpPWpGaD
Entacapone—COMT—Metabolism—PLCB1—Alzheimer's disease	3.66e-05	0.00112	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCA1—Alzheimer's disease	3.54e-05	0.00108	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TPI1—Alzheimer's disease	3.44e-05	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CHAT—Alzheimer's disease	3.44e-05	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MAOB—Alzheimer's disease	3.29e-05	0.00101	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GAPDH—Alzheimer's disease	3.17e-05	0.000968	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.14e-05	0.000957	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.11e-05	0.000948	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—A2M—Alzheimer's disease	3.06e-05	0.000935	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARGC1A—Alzheimer's disease	3.05e-05	0.000932	CbGpPWpGaD
Entacapone—COMT—Metabolism—HMOX1—Alzheimer's disease	3.04e-05	0.000928	CbGpPWpGaD
Entacapone—COMT—Metabolism—LPL—Alzheimer's disease	2.78e-05	0.000848	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.73e-05	0.000833	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ACHE—Alzheimer's disease	2.66e-05	0.000813	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—INPP5D—Alzheimer's disease	2.63e-05	0.000804	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTHFR—Alzheimer's disease	2.5e-05	0.000764	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ENO1—Alzheimer's disease	2.5e-05	0.000762	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS1—Alzheimer's disease	2.5e-05	0.000762	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2D6—Alzheimer's disease	2.45e-05	0.000747	CbGpPWpGaD
Entacapone—COMT—Metabolism—CALM1—Alzheimer's disease	2.34e-05	0.000714	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOE—Alzheimer's disease	2.33e-05	0.000711	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BCHE—Alzheimer's disease	2.32e-05	0.000708	CbGpPWpGaD
Entacapone—COMT—Metabolism—CAV1—Alzheimer's disease	2.31e-05	0.000705	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLCB1—Alzheimer's disease	2.19e-05	0.000668	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.15e-05	0.000656	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCA1—Alzheimer's disease	2.12e-05	0.000648	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARG—Alzheimer's disease	2.03e-05	0.000619	CbGpPWpGaD
Entacapone—COMT—Metabolism—INS—Alzheimer's disease	1.99e-05	0.000608	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARGC1A—Alzheimer's disease	1.83e-05	0.000558	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMOX1—Alzheimer's disease	1.82e-05	0.000556	CbGpPWpGaD
Entacapone—COMT—Metabolism—NOS3—Alzheimer's disease	1.75e-05	0.000533	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LPL—Alzheimer's disease	1.67e-05	0.000508	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—Alzheimer's disease	1.6e-05	0.000487	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTHFR—Alzheimer's disease	1.5e-05	0.000458	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CALM1—Alzheimer's disease	1.4e-05	0.000428	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOE—Alzheimer's disease	1.4e-05	0.000426	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAV1—Alzheimer's disease	1.38e-05	0.000422	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARG—Alzheimer's disease	1.22e-05	0.000371	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—INS—Alzheimer's disease	1.19e-05	0.000364	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NOS3—Alzheimer's disease	1.05e-05	0.000319	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—Alzheimer's disease	9.57e-06	0.000292	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—Alzheimer's disease	8.03e-06	0.000245	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—Alzheimer's disease	4.81e-06	0.000147	CbGpPWpGaD
